Gefitinib Pliva

Gefitinib Pliva is an oral medication used to treat certain types of cancer. This pharmaceutical is manufactured by Pliva Hrvatska D.O.O. and is designed for targeted therapy.

Gefitinib Pliva is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by targeting and inhibiting the growth of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its ability to interfere with the cancer cell's ability to divide and grow.

Common effects of Gefitinib Pliva may include skin rash, diarrhea, and appetite loss. Some users might experience dry skin or changes in their nails. These effects can vary from person to person and are not exhaustive.

Gefitinib Pliva should be handled with care. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or those taking other medications should consult their doctor before starting this treatment.

Gefitinib Pliva may interact with other medications, including those that are metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.